<DOC>
	<DOC>NCT01684046</DOC>
	<brief_summary>The purpose of this study was to evaluate the performance of Opti-Free® PureMoist® Multi-purpose Disinfecting Solution (MPDS) compared to AMO RevitaLens OcuTec® MPDS (US brand name)/COMPLETE RevitaLens (Europe brand name) in silicone hydrogel contact lens wearers.</brief_summary>
	<brief_title>Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2</brief_title>
	<detailed_description>In this 2-period crossover study, eligible participants were randomized to either Opti-Free® PureMoist MPDS or RevitaLens MPDS in Period 1 for use with their habitual contact lenses, after which they switched to the alternate solution in Period 2. Each period was 30 days in length. A 2-day washout period during which participants refrained from using a multi-purpose contact lens solution preceded Period 1 and Period 2.</detailed_description>
	<mesh_term>Hyperopia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Wear single vision sphere silicone hydrogel contact lenses (CooperVision™ Biofinity®, Alcon® Air Optix® Aqua, Bausch+Lomb® PureVision™ or ACUVUE® Oasys™) on a daily wear basis (a minimum of 8 hours per day, 5 days a week) for at least 1 month prior to Visit 1; Willing to wear lenses on a daily wear basis (a minimum of 8 hours per day, 5 days a week) for the duration of the study, and wear lenses for 16 hours on 2 days during the study; Must have habitually used a biguanide preserved multipurpose solution (other than RevitaLens) for at least 30 days prior to Visit 1; Vision correctable to 20/30 Snellen (feet) or better in each eye at distance with prestudy contact lenses at Visit 1; Have access, capability and willingness to review and answer text messages; Read, sign, and date IRB/IEC approved informed consent and privacy document before enrollment; Willing to follow the study procedures and visit schedule; Other protocoldefined inclusion criteria may apply. Need to wear lenses on an extended wear (i.e overnight) basis during the study; Known sensitivity or intolerance to biguanide, polyquaternium1 (POLYQUAD), or ALDOX preserved lens care products; Monocular (only one eye with functional vision) or fit with only one lens; Wearing toric or multifocal contact lenses or fit with monovision; Use of additional lens care products other than a biguanide preserved multipurpose solution such as daily or enzyme cleaners within the 1 week prior to Visit 1; Use of topical ocular overthecounter (OTC) or prescribed topical ocular medications, with the exception of rewetting drops, within 7 days prior to Visit 1; Abnormal ocular condition observed during the Visit 1 slitlamp examination; Current or history of ocular infections or severe inflammation within 6 months prior to Visit 1; Ocular surgery within the 12 months prior to Visit 1; Participation in any other clinical trial within 30 days of enrollment; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>multi-purpose solution</keyword>
	<keyword>silicone hydrogel</keyword>
	<keyword>contact lenses</keyword>
	<keyword>comfort</keyword>
	<keyword>Opti-Free</keyword>
	<keyword>RevitaLens</keyword>
</DOC>